Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$3,746,073 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Derivatives in DNLI
reported options exposure · as of Jun 30, 2026CallValue
$11,131,616
CallShares
432,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in DNLI
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,131,616 | 432,800 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $3,746,073 | 195,108 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $225,609 | 16,595 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,479,588 | 416,074 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,313,996 | 45,108 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,800,610 | 120,612 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,449,314 | 363,027 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,592,197 | 260,587 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $36,514 | 1,313 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $767,250 | 25,000 | Call | Sole | 2022-11-15 | |
| 2021-12-31 | $574,180 | 12,874 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $321,063 | 6,364 | Shares | Sole | 2021-12-01 | |
| 2021-06-30 | $7,995,702 | 101,934 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,888,624 | 68,102 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,194,198 | 50,074 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,291,686 | 63,960 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $950,197 | 54,266 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||